TACE plus donafenib and immune checkpoint inhibitors for intermediate HCC (CHANCE2410 study): a propensity score matching analysis.

Eur Radiol Exp · 2026 · PMC13272723 · PMID 42301580

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

However, in patients within up-to-seven criteria, numerical trends favored combination therapy, but differences did not reach statistical significance, likely owing to fewer events and good outcomes in both arms.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.